Ultragenyx Pharmaceu (RARE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2000 | 12-1999 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | 3,771 | N/A |
| Receivables | 9,640 | N/A |
| Inventories | 11,179 | N/A |
| Other current assets | 7,026 | 0 |
| TOTAL | $31,616 | $N/A |
| Non-Current Assets | ||
| PPE Net | 238,850 | N/A |
| TOTAL | $238,850 | $N/A |
| Total Assets | $295,381 | $N/A |
| Liabilities | ||
| Current Liabilities | ||
| TOTAL | $54,730 | $N/A |
| Non-Current Liabilities | ||
| Long Term Debt | 51,000 | N/A |
| Other Non-Current Liabilities | 1,469 | 0 |
| TOTAL | $52,469 | $N/A |
| Total Liabilities | $128,124 | $N/A |
| Shareholders' Equity | ||
| Retained earnings | 52,849 | N/A |
| Other shareholders' equity | 114,408 | 0 |
| TOTAL | $167,257 | $N/A |
| Total Liabilities And Equity | $295,381 | $0 |